Antares Therapeutics News and Activities

Acquisition, funding and merger involving Antares Therapeutics.

• Antares Therapeutics has just announced a $177 Million fundraising (posted on June 11 2025).

View the org chart displaying its 19 main executives

Most searched biographies at Antares Therapeutics

• Adam Friedman, Chief Executive Officer and Director
• Shelley Chu, Director
• Keith Flaherty, Director

Create your alert
to follow the executive moves at Antares Therapeutics.

Antares Therapeutics has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Antares Therapeutics

Social media about Antares Therapeutics

• Antares Therapeutics on Wikipedia, Google News & Yahoo Finance
• Antares Therapeutics on LinkedIn, X (Twitter) & YouTube